Previous close | 13.82 |
Open | 11.75 |
Bid | 23.40 |
Ask | 32.40 |
Strike | 395.00 |
Expiry date | 2024-05-10 |
Day's range | 11.75 - 13.82 |
Contract range | N/A |
Volume | |
Open interest | 12 |
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...